drugset / Trial / NCT02475070

Vildagliptin Versus Dapagliflozin on Glucagon

NCT02475070

Phase 4 Completed 28 enrolled Lund University
RandomizedCrossoverOpen-labelBasic science

Summary

The aim of the study is to assess if vildagliptin and dapagliflozin have dissociated effects on glucagon secretion after a mixed meal ingestion in metformin-treated subjects with type 2 diabetes and whether this is associated with effects on glucose homeostasis.

Timeline

Start
2016-01
Primary completion
2017-06
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dapagliflozin Small molecule 10 mg
Comparator Vildagliptin Other / unclassified 50 mg